H.R. 4127 · 117th Congress
Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2021
- Stage
- In committee
- Sponsor
- Danny Davis
- Introduced
- 2021-06-24
- Latest action
- 2021-06-25 · Referred to the Subcommittee on Health.
Summary
Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2021 or the DISARM Act of 2021
This bill requires additional payment under Medicare's inpatient prospective payment system for services that involve certain antimicrobial drugs, in accordance with specified limitations. Additionally, the Government Accountability Office must report on the barriers to developing such antimicrobial drugs and must recommend ways to address such barriers.